Dysferlin (DYSF) is an important molecule related to monocyte differentiation and inflammatory cytokine release [74,75], while the hypermethylation of DYSF’s promoter can upregulate its expression and facilitate the activation of monocytes, which further promotes the pathogenesis of atherosclerosis [76]. The gene discussed is DYSF; the disease is atherosclerosis.